HLA Expression in Uveal Melanoma: An Indicator of Malignancy and a Modifiable Immunological Target

Souri, Z.; Wierenga, A.P.A.; Mulder, A.; Jochemsen, A.G.; Jager, M.J. (2019)

Article / Letter to editor

• uveal melanoma
• inflammation
• HLA Class I
• HLA Class II
• chromosome 3
• BAP1

• All authors: Souri, Z.; Wierenga, A.P.A.; Mulder, A.; Jochemsen, A.G.; Jager, M.J.
• Date: 2019-08-31
• Journal: Cancers
• Volume: 11
• Issue: 8
• DOI: doi:10.3390/cancers11081132